Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;115(6):934-40.
doi: 10.1016/j.ophtha.2007.08.012. Epub 2007 Oct 15.

Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma

Affiliations

Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma

Felipe A Medeiros et al. Ophthalmology. 2008 Jun.

Abstract

Purpose: To investigate whether long-term intraocular pressure (IOP) fluctuations are a risk factor for conversion from ocular hypertension to glaucoma.

Design: Observational cohort study.

Participants: The study included 252 eyes of 126 patients with ocular hypertension observed untreated as part of the Diagnostic Innovations in Glaucoma Study. At baseline, ocular hypertensive eyes had elevated IOP, normal visual fields (VFs) on standard automated perimetry, and normal optic discs as evaluated by stereophotograph assessment.

Methods: Glaucoma conversion was defined as development of reproducible VF loss or optic disc damage. Analyses included all IOP measurements from the baseline visit to time of progression (for converters) and last follow-up (for nonconverters). Mean IOP and IOP fluctuation were calculated as the arithmetic mean and standard deviation (SD), respectively, of all available IOP measurements per eye.

Main outcome measures: Univariable and multivariable Cox regression analyses were used to evaluate the association between IOP fluctuation and time to progression. Multivariable models adjusted for age, mean IOP, central corneal thickness, vertical cup-to-disc ratio, and pattern SD.

Results: Forty eyes of 31 subjects developed glaucoma during follow-up. Mean IOPs during follow-up were 25.4+/-4.2 mmHg for the eyes that converted to glaucoma and 24.1+/-3.5 mmHg for the eyes that did not. Corresponding values for IOP fluctuation were 3.16+/-1.35 mmHg and 2.77+/-1.11 mmHg, respectively. Intraocular pressure fluctuation was not a risk factor for conversion to glaucoma both in univariable analysis (hazard ratio [HR], 1.30 per 1 mmHg higher; 95% confidence interval [CI], 0.76-1.96; P = 0.092) and in multivariable analysis (adjusted HR, 1.08 per 1 mmHg higher; 95% CI, 0.79-1.48; P = 0.620). Mean IOP during follow-up was a significant risk factor for progression both in univariable analysis (HR = 1.16 per 1 mmHg higher; 95% CI, 1.04-1.31; P = 0.010) and in multivariable analysis (adjusted HR, 1.20 per 1 mmHg higher; 95% CI, 1.06-1.36; P = 0.005).

Conclusion: Long-term IOP fluctuations do not appear to be significantly associated with the risk of developing glaucoma in untreated ocular hypertensive subjects.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier curve showing the cumulative probability of development of glaucoma in at least one eye during follow-up.
Figure 2
Figure 2
Scatterplot of long-term intraocular pressure (IOP) fluctuation values versus mean IOP.
Figure 3
Figure 3
Covariate-adjusted survivorship functions for eyes with long-term intraocular pressure (IOP) fluctuation ≤ 3 mmHg and for eyes with long-term IOP fluctuation > 3 mmHg. Survivorship functions are reported at mean levels of the covariates.
Figure 4
Figure 4
Covariate-adjusted survivorship functions for eyes with mean intraocular pressure (IOP) ≤ 24 mmHg and for eyes with mean IOP > 24 mmHg. Survivorship functions are reported at mean levels of the covariates.

Similar articles

Cited by

References

    1. Leske MC, Heijl A, Hussein M, et al. Early Manifest Glaucoma Trial Group Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121:48–56. - PubMed
    1. Kass MA, Heuer DK, Higginbotham EJ, et al. Ocular Hypertension Treatment Study Group The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13. discussion 829–30. - PubMed
    1. Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–53. - PubMed
    1. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7 The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429–40. - PubMed
    1. Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126:498–505. - PubMed

MeSH terms